speb/financial-data huggingface dataset:
Financial ratios for MORG.OL — quarterly report dated 2025-03-31
Total revenue: 54007633.58778626
Net income: 22137404.58015267
Capital expenditures: 2003816.7938931298
Operating cash flow: -53244274.8091603
Depreciation & amortization: 1431297.709923664
Net tangible assets: 877671755.7251908
Owner earnings: 21564885.49618321
Return on net tangible assets (%): 2.4570558817134165
Buffett classification: The Gruesome
Stock price: 8.662213740458014
P/E ratio: 4.8485499198491375
Shares outstanding: 49564379
Book value: 883396946.5648861
P/B ratio: 0.4860071641412828
Market cap (USD): 429337244.81106865
Debt to equity: 4.532512421689346
Effective tax rate (%): 23.178807947019866
COGS to revenue (%): 0
SG&A to revenue (%): 1.76678445229682
Free cash flow (dilution-adjusted): -55248091.603053436
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -102.29681978798588
Revenue growth (%): 3.889047291955572
Rule of 40 score: -98.4077724960303
Financial ratios for MORG.OL — quarterly report dated 2025-06-30
Total revenue: 59880834.16087388
Net income: 24131082.42303873
Capital expenditures: 3574975.173783515
Operating cash flow: -474180734.85600793
Net tangible assets: 872492552.1350546
Owner earnings: 20556107.249255214
Return on net tangible assets (%): 2.356020942408377
Buffett classification: The Gruesome
Stock price: 10.012909632571995
P/E ratio: 7.253269434342223
Shares outstanding: 49564379
Book value: 878748758.6891747
P/B ratio: 0.5647617057938756
Market cap (USD): 496283647.92154914
Debt to equity: 5.4134930500621605
Effective tax rate (%): 23.34384858044164
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -477755710.0297915
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -797.844112769486
Revenue growth (%): 10.874760071724083
Rule of 40 score: -786.9693526977619
Financial ratios for MORG.OL — quarterly report dated 2025-12-31
Total revenue: 60995024.875621885
Net income: 29552238.805970147
Capital expenditures: 5771144.278606965
Operating cash flow: 24079601.99004975
Net tangible assets: 925671641.7910447
Owner earnings: 23781094.52736318
Return on net tangible assets (%): 2.569063742878641
Buffett classification: The Gruesome
Stock price: 10.99203187250996
P/E ratio: 5.560776974583149
Shares outstanding: 49564379
Book value: 932736318.4079609
P/B ratio: 0.584102090759237
Market cap (USD): 544813233.7091633
Debt to equity: 4.8102197567740514
Effective tax rate (%): 24.427480916030536
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 18308457.711442783
Buyback yield (%): 0
Receivables turnover: 14.25581395348837
Capitalized R&D asset: 0
FCF margin (%): 30.0163132137031
Revenue growth (%): 1.8606800161712085
Rule of 40 score: 31.87699322987431
Financial ratios for MORG.OL — annual report dated 2025-12-31
Total revenue: 237810945.2736318
Net income: 102487562.18905471
Capital expenditures: 17910447.761194028
Operating cash flow: -248855721.39303482
Depreciation & amortization: 6169154.228855721
Net tangible assets: 925671641.7910447
Owner earnings: 90746268.6567164
Return on net tangible assets (%): 9.803289261528539
Buffett classification: The Gruesome
Stock price: 10.99203187250996
P/E ratio: 5.315896115317566
Shares outstanding: 49564379
Book value: 932736318.4079609
P/B ratio: 0.584102090759237
Market cap (USD): 544813233.7091633
Debt to equity: 4.8102197567740514
Effective tax rate (%): 23.703703703703702
COGS to revenue (%): 0
SG&A to revenue (%): 1.5481171548117154
Free cash flow (dilution-adjusted): -266766169.15422884
Buyback yield (%): 0
Receivables turnover: 55.581395348837205
Capitalized R&D asset: 0
FCF margin (%): -112.17573221757323
Revenue growth (%): 12.219825487307311
Rule of 40 score: -99.95590673026592
Financial ratios for NCA — annual report dated 2022-02-28
Total revenue: -1042267
Net income: -1450508
Capital expenditures: 0
Net tangible assets: 341803795
Owner earnings: -1450508
Return on net tangible assets (%): -0.4243686059717388
Buffett classification: The Gruesome
Stock price: 8.05
Shares outstanding: 33121987
Book value: 341803795
P/B ratio: 0.7800732445056674
Market cap (USD): 266631995.35000002
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 28594613
Receivables turnover: -0.3049798170882474
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCA — annual report dated 2023-02-28
Total revenue: -25949182
Net income: -26132574
Capital expenditures: 0
Net tangible assets: 305142814
Owner earnings: -26132574
Return on net tangible assets (%): -8.564046997351214
Buffett classification: The Gruesome
Stock price: 7.64
Shares outstanding: 33121987
Book value: 305142814
P/B ratio: 0.8292903161075259
Market cap (USD): 253051980.67999998
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -8064066
Receivables turnover: -8.070133066538867
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCA — annual report dated 2024-02-29
Total revenue: 17677882
Net income: 17534948
Capital expenditures: 0
Net tangible assets: 311156109
Owner earnings: 17534948
Return on net tangible assets (%): 5.635418200964841
Buffett classification: The Gruesome
Stock price: 8
P/E ratio: 15.111302069444402
Shares outstanding: 33121987
Book value: 311156109
P/B ratio: 0.8515850672242467
Market cap (USD): 264975896
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.7601306536608854
Buyback yield (%): 0
Retained earnings: -2050771
Receivables turnover: 5.9075873136071575
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCA — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 309388489
Buffett classification: The Gruesome
Stock price: 8.2
Shares outstanding: 33121987
Book value: 309388489
P/B ratio: 0.8778616627847455
Market cap (USD): 271600293.4
Debt to equity: 9.890477858082174e-06
Buyback yield (%): 0
Retained earnings: -3818391
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCA — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 293035327
Buffett classification: The Gruesome
Stock price: 8.25
Shares outstanding: 33121987
Book value: 293035327
P/B ratio: 0.9325032430304896
Market cap (USD): 273256392.75
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -20171553
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCA — annual report dated 2025-08-31
Total revenue: -6970594
Net income: -7113366
Capital expenditures: 0
Net tangible assets: 293035327
Owner earnings: -7113366
Return on net tangible assets (%): -2.4274772850169017
Buffett classification: The Gruesome
Stock price: 8.25
Shares outstanding: 33121987
Book value: 293035327
P/B ratio: 0.9325032430304896
Market cap (USD): 273256392.75
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -20171553
Receivables turnover: -2.441440712545729
Capitalized R&D asset: 0
Revenue growth (%): -139.43116036185782
Rule of 40 score: -139.43116036185782
Financial ratios for NR21.PA — annual report dated 2021-12-31
Total revenue: 0
Gross profit: -166659.0909090909
Operating income: -166496.5909090909
Net income: -175620.45454545456
Capital expenditures: 0
Operating cash flow: -251785.22727272726
Depreciation & amortization: -3636.3636363636365
Net tangible assets: 6378717.045454546
Owner earnings: -179256.8181818182
Return on net tangible assets (%): -2.8102331065077744
Buffett classification: The Gruesome
Stock price: 197.95454545454544
Shares outstanding: 73618
Book value: 6378717.045454546
P/B ratio: 2.284631474233116
Market cap (USD): 14573017.727272727
Debt to equity: 0.00017814924666918804
Current ratio: 288.0282208588957
Quick ratio: 288.0282208588957
Interest coverage ratio: -1526.21875
Free cash flow (dilution-adjusted): -251785.22727272726
Buyback yield (%): 0
Retained earnings: -928988.6363636364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.609723932150063
Rule of 40 score: 0
Financial ratios for NR21.PA — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -114640.4255319149
Operating income: -229280.8510638298
Net income: -98096.80851063831
Capital expenditures: 0
Operating cash flow: -89034.0425531915
Net tangible assets: 5873469.14893617
Owner earnings: -98096.80851063831
Return on net tangible assets (%): -1.6701681071808483
Buffett classification: The Gruesome
Stock price: 136.17021276595744
Shares outstanding: 73618
Book value: 5873469.14893617
P/B ratio: 1.7067560021524848
Market cap (USD): 10024578.723404255
Debt to equity: 0.00018112460630302765
Current ratio: 441.77753831417624
Quick ratio: 441.77753831417624
Free cash flow (dilution-adjusted): -89034.0425531915
Buyback yield (%): 0
Retained earnings: -967787.2340425532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.9029630422409314
Rule of 40 score: 0
Financial ratios for NR21.PA — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -119666.66666666666
Operating income: -119666.66666666666
Net income: 213333.3333333333
Capital expenditures: 0
Operating cash flow: -95921.11111111111
Net tangible assets: 6349000
Owner earnings: 213333.3333333333
Return on net tangible assets (%): 3.360109203549115
Buffett classification: The Gruesome
Stock price: 60
P/E ratio: 20.7050625
Shares outstanding: 73618
Book value: 6348999.999999999
P/B ratio: 0.6957127106630967
Market cap (USD): 4417080
Debt to equity: 0
Current ratio: 169.55457227138643
Quick ratio: 169.55457227138643
Free cash flow (dilution-adjusted): -95921.11111111111
Buyback yield (%): 0
Retained earnings: -797444.4444444444
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8848442422121106
Rule of 40 score: 0
Financial ratios for NR21.PA — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -121145.83333333334
Operating income: -121145.83333333334
Net income: 219479.1666666667
Capital expenditures: 0
Operating cash flow: -130208.33333333334
Net tangible assets: 6171562.5
Owner earnings: 219479.1666666667
Return on net tangible assets (%): 3.556298209192027
Buffett classification: The Gruesome
Stock price: 36.66666666666667
P/E ratio: 12.29878310393925
Shares outstanding: 73618
Book value: 6171562.5
P/B ratio: 0.43738140327780317
Market cap (USD): 2699326.666666667
Debt to equity: 1.6878491737978295e-05
Current ratio: 239.90725806451613
Quick ratio: 239.90725806451613
Interest coverage ratio: -25.282608695652176
Free cash flow (dilution-adjusted): -130208.33333333334
Buyback yield (%): 0
Retained earnings: -528229.1666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9629023274654422
Rule of 40 score: 0
Financial ratios for NR21.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6171562.5
Buffett classification: The Gruesome
Stock price: 36.66666666666667
Shares outstanding: 73618
Book value: 6171562.5
P/B ratio: 0.43738140327780317
Market cap (USD): 2699326.666666667
Debt to equity: 1.6878491737978295e-05
Current ratio: 239.90725806451613
Quick ratio: 239.90725806451613
Buyback yield (%): 0
Retained earnings: -528229.1666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NR21.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 7075155.294117647
Buffett classification: The Gruesome
Stock price: 40
Shares outstanding: 73618
Book value: 7075155.294117647
P/B ratio: 0.4162057053996071
Market cap (USD): 2944720
Debt to equity: 1.2803709816720715e-05
Current ratio: 485.0987684134267
Quick ratio: 485.0987684134267
Buyback yield (%): 0
Retained earnings: -491645.8823529412
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXPI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 209.24
Shares outstanding: 252471079
Market cap (USD): 52827048569.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXPI — annual report dated 2022-12-31
Total revenue: 14047872340.425533
Gross profit: 7996808510.638298
Operating income: 4036170212.765958
Net income: 3013829787.2340426
Capital expenditures: 3191489.361702128
Operating cash flow: 4143617021.276596
Depreciation & amortization: 1329787234.0425532
Net tangible assets: -4047872340.4255323
Owner earnings: 4340425531.914894
Return on net tangible assets (%): -107.22733245729303
Capex to operating income (%): 0.0790722192936215
Buffett classification: The Great
Stock price: 148.11
P/E ratio: 12.407300395357783
Shares outstanding: 252471079
Book value: 8234042553.191492
P/B ratio: 4.541328426362867
Market cap (USD): 37393491510.69
Debt to equity: 1.4425064599483202
Current ratio: 2.120795107033639
Quick ratio: 1.5758409785932723
Effective tax rate (%): 15.730002973535534
Interest coverage ratio: 8.885245901639344
COGS to revenue (%): 43.07459295721318
R&D to revenue (%): 16.26656569481257
SG&A to revenue (%): 8.072699734948884
Free cash flow (dilution-adjusted): 2451063829.787234
Buyback yield (%): 4.056912621176497
Retained earnings: -4228723404.2553196
Inventory turnover: 3.191919191919192
Receivables turnover: 13.755208333333334
Capitalized R&D asset: 2285106382.9787235
ROCI (R&D-adjusted, %): 23.63208826987428
FCF margin (%): 17.447936387731914
Rule of 40 score: 17.447936387731914
Financial ratios for NXPI — annual report dated 2023-12-31
Total revenue: 14751111111.11111
Gross profit: 8392222222.222222
Operating income: 4084444444.444444
Net income: 3135555555.5555553
Capital expenditures: 1111111.111111111
Operating cash flow: 3903333333.333333
Depreciation & amortization: 1228888888.8888888
Net tangible assets: -2481111111.111111
Owner earnings: 4363333333.333334
Return on net tangible assets (%): -175.86206896551727
Capex to operating income (%): 0.02720348204570185
Buffett classification: The Great
Stock price: 219.79
P/E ratio: 17.697220626530473
Shares outstanding: 252471079
Book value: 9955555555.555557
P/B ratio: 5.573834442864843
Market cap (USD): 55490618453.409996
Debt to equity: 1.2472098214285712
Current ratio: 1.912916565312576
Quick ratio: 1.393821454633909
Effective tax rate (%): 15.602625298329356
Interest coverage ratio: 8.39269406392694
COGS to revenue (%): 43.107863814401924
R&D to revenue (%): 18.213317264236213
SG&A to revenue (%): 8.730039168424224
Free cash flow (dilution-adjusted): 2328888888.888889
Buyback yield (%): 2.1084645163620475
Retained earnings: -3103333333.3333335
Inventory turnover: 2.6818181818181817
Receivables turnover: 14.850111856823267
Capitalized R&D asset: 4217687943.262411
ROCI (R&D-adjusted, %): 19.14669924875786
Rosenberg metric: 0.17303951996689423
FCF margin (%): 15.787887918047605
Revenue growth (%): 5.0060162396398535
Rule of 40 score: 20.793904157687457
Financial ratios for NXPI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 232.52
Shares outstanding: 252471079
Market cap (USD): 58704575289.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXPI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 202.28
Shares outstanding: 252471079
Market cap (USD): 51069849860.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXPI — annual report dated 2024-12-31
Total revenue: 13139583333.333334
Gross profit: 7415625000
Operating income: 3616666666.666667
Net income: 2647916666.666667
Capital expenditures: 35416666.66666667
Operating cash flow: 2897916666.666667
Depreciation & amortization: 963541666.6666667
Net tangible assets: -1648958333.3333335
Owner earnings: 3576041666.6666675
Return on net tangible assets (%): -216.86670878079596
Capex to operating income (%): 0.97926267281106
Buffett classification: The Great
Stock price: 202.28
P/E ratio: 19.28680403844028
Shares outstanding: 252471079
Book value: 9928125000
P/B ratio: 5.143957178230532
Market cap (USD): 51069849860.12
Debt to equity: 1.1388101983002832
Current ratio: 2.357972885732731
Quick ratio: 1.5974822466107164
Effective tax rate (%): 17.586318167150694
Interest coverage ratio: 8.72361809045226
COGS to revenue (%): 43.56270810210877
R&D to revenue (%): 18.606310448707784
SG&A to revenue (%): 9.227842080228317
Free cash flow (dilution-adjusted): 1505208333.3333335
Buyback yield (%): 2.8004944938171255
Retained earnings: -1889583333.3333335
Inventory turnover: 2.3323429541595924
Receivables turnover: 12.222868217054264
Capitalized R&D asset: 4998943439.716312
ROCI (R&D-adjusted, %): 13.20900551785206
Rosenberg metric: -0.3634977253928867
FCF margin (%): 11.455525606469005
Revenue growth (%): -10.924789093100324
Rule of 40 score: 0.5307365133686801
Financial ratios for NXPI — quarterly report dated 2025-03-31
Total revenue: 3081521739.1304345
Gross profit: 1695652173.9130435
Operating income: 766304347.8260869
Net income: 540217391.3043478
Capital expenditures: 1086956.5217391304
Operating cash flow: 614130434.7826086
Depreciation & amortization: 227173913.04347825
Net tangible assets: -1518478260.8695652
Owner earnings: 766304347.8260869
Return on net tangible assets (%): -50.465282748747306
Capex to operating income (%): 0.14184397163120568
Buffett classification: The Great
Stock price: 185.87
P/E ratio: 21.716627513798596
Shares outstanding: 252471079
Book value: 10518478260.869566
P/B ratio: 4.461367727336117
Market cap (USD): 46926799453.73
Debt to equity: 1.2116358375529606
Current ratio: 2.0849571317225255
Quick ratio: 1.4744089373863343
Effective tax rate (%): 20.602218700475436
Interest coverage ratio: 6.650943396226414
COGS to revenue (%): 44.973544973544975
R&D to revenue (%): 19.294532627865962
SG&A to revenue (%): 9.911816578483245
Free cash flow (dilution-adjusted): 297826086.95652175
Buyback yield (%): 0.7018331314320608
Retained earnings: -1742391304.347826
Inventory turnover: 0.5425531914893617
Receivables turnover: 2.674528301886792
Capitalized R&D asset: 594565217.3913044
ROCI (R&D-adjusted, %): 4.889234238352073
FCF margin (%): 9.664902998236332
Rule of 40 score: 9.664902998236332
Financial ratios for NXPI — quarterly report dated 2025-06-30
Total revenue: 3442352941.1764708
Gross profit: 1837647058.8235295
Operating income: 807058823.5294118
Net income: 537647058.8235295
Capital expenditures: 0
Operating cash flow: 916470588.2352941
Depreciation & amortization: 243529411.7647059
Net tangible assets: -1941176470.5882354
Owner earnings: 781176470.5882354
Return on net tangible assets (%): -40.24242424242425
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 214.67
P/E ratio: 50.282729449421936
Shares outstanding: 252471079
Book value: 11689411764.705883
P/B ratio: 4.63650075982191
Market cap (USD): 54197966528.93
Debt to equity: 1.0797101449275361
Current ratio: 1.736164445448385
Quick ratio: 1.2028461712220466
Effective tax rate (%): 19.30116472545757
Interest coverage ratio: 5.965217391304348
COGS to revenue (%): 46.61654135338346
R&D to revenue (%): 19.583048530416953
SG&A to revenue (%): 9.501025290498974
Free cash flow (dilution-adjusted): 637647058.8235295
Buyback yield (%): 0.4428210417671148
Retained earnings: -1672941176.4705882
Inventory turnover: 0.5777213045319779
Receivables turnover: 2.7320261437908497
Capitalized R&D asset: 1072476342.7109976
ROCI (R&D-adjusted, %): 4.138744916556337
Rosenberg metric: 0.2388213786428649
FCF margin (%): 18.52358168147642
Revenue growth (%): 11.709513435003647
Rule of 40 score: 30.233095116480065
Financial ratios for NXPI — quarterly report dated 2025-09-30
Total revenue: 3732941176.470588
Gross profit: 2102352941.1764708
Operating income: 1052941176.4705882
Net income: 760000000
Capital expenditures: 1176470.5882352942
Operating cash flow: 688235294.117647
Depreciation & amortization: 236470588.23529413
Net tangible assets: -1429411764.7058823
Owner earnings: 995294117.6470588
Return on net tangible assets (%): -69.62962962962963
Capex to operating income (%): 0.111731843575419
Buffett classification: The Great
Stock price: 224.78
P/E ratio: 30.87847372730418
Shares outstanding: 252471079
Book value: 12267058823.529415
P/B ratio: 4.626247412196892
Market cap (USD): 56750449137.62
Debt to equity: 1.1733959911767524
Current ratio: 2.3748255651688526
Quick ratio: 1.690482835612615
Effective tax rate (%): 18.61635220125786
Interest coverage ratio: 7.584745762711864
COGS to revenue (%): 43.681058934762056
R&D to revenue (%): 18.121651433974158
SG&A to revenue (%): 9.013551843681059
Free cash flow (dilution-adjusted): 431764705.88235295
Buyback yield (%): 0.11194521405574584
Retained earnings: -1250588235.2941177
Inventory turnover: 0.5652528548123981
Receivables turnover: 2.8977168949771688
Capitalized R&D asset: 1324335933.5038364
ROCI (R&D-adjusted, %): 3.84519094388205
Rosenberg metric: 0.39267015706806296
FCF margin (%): 11.566341002206114
Revenue growth (%): 8.441558441558437
Rule of 40 score: 20.00789944376455
Financial ratios for NXPI — quarterly report dated 2025-12-31
Total revenue: 4038823529.4117646
Gross profit: 2125882352.9411764
Operating income: 881176470.5882353
Net income: 550588235.2941177
Capital expenditures: 0
Operating cash flow: 1048235294.117647
Depreciation & amortization: 252941176.47058824
Net tangible assets: -2105882352.9411764
Owner earnings: 803529411.7647059
Return on net tangible assets (%): -38.15642458100559
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 215.21
P/E ratio: 22.748744927300137
Shares outstanding: 252471079
Book value: 12295294117.647057
P/B ratio: 4.419113556104823
Market cap (USD): 54334300911.590004
Debt to equity: 1.1694574681848628
Current ratio: 2.045864467920639
Quick ratio: 1.3818603452718372
Effective tax rate (%): 20.59748427672956
Interest coverage ratio: 5.89763779527559
COGS to revenue (%): 44.50917564812118
R&D to revenue (%): 19.370812700262164
SG&A to revenue (%): 10.457325953976113
Free cash flow (dilution-adjusted): 750588235.2941177
Buyback yield (%): 0.7318527194645614
Retained earnings: -1592941176.4705882
Inventory turnover: 0.5929375242530074
Receivables turnover: 3.254028436018957
Capitalized R&D asset: 1458047058.8235295
ROCI (R&D-adjusted, %): 3.385129012576403
Rosenberg metric: 0.03478260869565184
FCF margin (%): 18.584328575589865
Revenue growth (%): 8.194138039710053
Rule of 40 score: 26.77846661529992
Financial ratios for NXPI — annual report dated 2025-12-31
Total revenue: 14434117647.058825
Gross profit: 7901176470.588236
Operating income: 3570588235.294118
Net income: 2432941176.470588
Capital expenditures: 2352941.1764705884
Operating cash flow: 3317647058.8235297
Depreciation & amortization: 978823529.4117647
Net tangible assets: -2105882352.9411764
Owner earnings: 3409411764.705882
Return on net tangible assets (%): -161.89944134078212
Capex to operating income (%): 0.06589785831960461
Buffett classification: The Great
Stock price: 215.21
P/E ratio: 22.33276391433825
Shares outstanding: 252471079
Book value: 12295294117.647057
P/B ratio: 4.419113556104823
Market cap (USD): 54334300911.590004
Debt to equity: 1.1694574681848628
Current ratio: 2.045864467920639
Quick ratio: 1.3818603452718372
Effective tax rate (%): 19.71460758542997
Interest coverage ratio: 6.512875536480688
COGS to revenue (%): 45.26041242155025
R&D to revenue (%): 19.235471513570786
SG&A to revenue (%): 9.813350721330181
Free cash flow (dilution-adjusted): 2142352941.1764705
Buyback yield (%): 1.946555014197162
Retained earnings: -1592941176.4705882
Inventory turnover: 2.154831199068685
Receivables turnover: 11.629383886255924
Capitalized R&D asset: 5301081004.901961
ROCI (R&D-adjusted, %): 11.603566506160114
Rosenberg metric: 0.19860648136544795
FCF margin (%): 14.842285434835764
Revenue growth (%): 9.852171723295314
Rule of 40 score: 24.69445715813108
Financial ratios for PDCC — annual report dated 2024-12-31
Total revenue: 1436757.0374999999
Net income: 18940535
Capital expenditures: 0
Operating cash flow: -210442227.5
Net tangible assets: 169019556.25
Owner earnings: 18940535
Return on net tangible assets (%): 11.206120416021385
Buffett classification: The Gruesome
Stock price: 15.84
P/E ratio: 5.7158196302269175
Shares outstanding: 6834639
Book value: 169019556.25
P/B ratio: 0.6405216305258167
Market cap (USD): 108260681.76
Debt to equity: 0.04908294450690229
COGS to revenue (%): 0
SG&A to revenue (%): 194.7415204500086
Free cash flow (dilution-adjusted): -210442227.5
Buyback yield (%): 0
Retained earnings: 1891885
Receivables turnover: 27.3375105244381
Capitalized R&D asset: 0
FCF margin (%): -14647.029526034254
Rule of 40 score: -14647.029526034254
Financial ratios for PDCC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 169320061.64383563
Buffett classification: The Gruesome
Stock price: 14.92
Shares outstanding: 6834639
Book value: 169320061.6438356
P/B ratio: 0.6022488586999195
Market cap (USD): 101972813.88
Debt to equity: 0.05632966568259375
Buyback yield (%): 0
Retained earnings: -13833550.684931507
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PN — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 2920277.272727273
Buffett classification: The Gruesome
Stock price: 69.4
Shares outstanding: 7744775
Book value: 3475032.2314049588
P/B ratio: 154.6711941669368
Market cap (USD): 537487385
Debt to equity: 0.23804880577836365
Current ratio: 1.9311792551397373
Quick ratio: 1.7121175612455797
Buyback yield (%): 0
Retained earnings: 1957257.9889807163
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QUB.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1127819548872178
Shares outstanding: 1770412012
Market cap (USD): 3740494551.6691723
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QUB.AX — annual report dated 2022-06-30
Total revenue: 1695448275.8620691
Gross profit: 1695448275.8620691
Operating income: 128551724.13793103
Net income: 88482758.62068966
Capital expenditures: 250413793.10344827
Depreciation & amortization: 175172413.79310346
Net tangible assets: 1444551724.137931
Owner earnings: 13241379.310344845
Return on net tangible assets (%): 0.9166427957605283
Capex to operating income (%): 194.79613733905578
Buffett classification: The Gruesome
Stock price: 1.7034482758620693
P/E ratio: 34.08353600654716
Shares outstanding: 1770412012
Book value: 2062689655.172414
P/B ratio: 1.4620741815640779
Market cap (USD): 3015805289.406897
Debt to equity: 0.6527466648834799
Current ratio: 1.3203943314849047
Quick ratio: 1.2850277264325325
Effective tax rate (%): 40.61269146608315
Interest coverage ratio: 30.06451612903226
COGS to revenue (%): 0
SG&A to revenue (%): 66.49853563293198
Free cash flow (dilution-adjusted): -62275862.06896552
Buyback yield (%): 9.174652493126603
Retained earnings: 187931034.48275864
Inventory turnover: 0
Receivables turnover: 2.8453703703703703
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.863692894453196
FCF margin (%): -3.673120728929385
Rule of 40 score: -3.673120728929385
Financial ratios for QUB.AX — annual report dated 2023-06-30
Total revenue: 1862649006.6225166
Gross profit: 1862649006.6225166
Operating income: 137417218.54304636
Net income: 111192052.98013245
Capital expenditures: 277615894.0397351
Depreciation & amortization: 183178807.94701988
Net tangible assets: 1412715231.7880795
Owner earnings: 16754966.887417257
Return on net tangible assets (%): 1.1860116257266107
Capex to operating income (%): 202.02409638554215
Buffett classification: The Gruesome
Stock price: 1.7483443708609272
P/E ratio: 27.837330027873733
Shares outstanding: 1770412012
Book value: 2008145695.3642385
P/B ratio: 1.5413671838802228
Market cap (USD): 3095289875.284768
Debt to equity: 0.6720641097516736
Current ratio: 0.8419997996192766
Quick ratio: 0.8162508766656646
Effective tax rate (%): 27.881040892193305
Interest coverage ratio: 4.377637130801688
COGS to revenue (%): 0
SG&A to revenue (%): 65.59055678020337
Free cash flow (dilution-adjusted): -32052980.13245033
Buyback yield (%): 0.09841913806582568
Retained earnings: 201059602.64900663
Inventory turnover: 0
Receivables turnover: 4.829326923076923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.439072394317987
FCF margin (%): -1.720827703903861
Revenue growth (%): 9.861741767110676
Rule of 40 score: 8.140914063206814
Financial ratios for QUB.AX — annual report dated 2024-06-30
Total revenue: 2144266666.6666667
Gross profit: 2144266666.6666667
Operating income: 130000000
Net income: 147933333.33333334
Capital expenditures: 344866666.6666667
Depreciation & amortization: 204933333.33333334
Net tangible assets: 1433800000
Owner earnings: 8000000
Return on net tangible assets (%): 0.5579578741804994
Capex to operating income (%): 265.28205128205127
Buffett classification: The Gruesome
Stock price: 2.32
P/E ratio: 27.76491122920234
Shares outstanding: 1770412012
Book value: 2074600000.0000002
P/B ratio: 1.9798302650342232
Market cap (USD): 4107355867.8399997
Debt to equity: 0.7510202770011889
Current ratio: 1.2718185313341022
Quick ratio: 1.1434063821607074
Effective tax rate (%): 23.74874034262681
Interest coverage ratio: 2.5390625
COGS to revenue (%): 0
SG&A to revenue (%): 68.24399950254943
Free cash flow (dilution-adjusted): -60733333.333333336
Buyback yield (%): 0.0389545014233553
Retained earnings: 252000000
Inventory turnover: 0
Receivables turnover: 4.941465662928254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6632789164208828
FCF margin (%): -2.8323591593085435
Revenue growth (%): 15.119201687643699
Rule of 40 score: 12.286842528335155
Financial ratios for RFF.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5037593984962405
Shares outstanding: 389722999
Market cap (USD): 586049622.556391
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFF.AX — annual report dated 2022-06-30
Total revenue: 43007586.20689655
Gross profit: 31239310.34482759
Operating income: 16971724.137931034
Net income: 144231724.13793105
Capital expenditures: 59075172.4137931
Depreciation & amortization: 4942758.620689656
Net tangible assets: 523677241.37931037
Owner earnings: 90099310.3448276
Return on net tangible assets (%): 17.205122397054257
Capex to operating income (%): 348.0799707424113
Buffett classification: The Gruesome
Stock price: 1.3655172413793104
P/E ratio: 3.6897116614069314
Shares outstanding: 389722999
Book value: 632421379.3103449
P/B ratio: 0.8414855852547024
Market cap (USD): 532173474.49655175
Debt to equity: 0.49925573411878366
Current ratio: 1.1332024140243318
Quick ratio: 0.7365648050579557
Effective tax rate (%): 0.6305146272741526
Interest coverage ratio: 2.1999821205077774
COGS to revenue (%): 27.363255881079525
SG&A to revenue (%): 0.054521255271724314
Free cash flow (dilution-adjusted): -81189655.1724138
Buyback yield (%): 0
Retained earnings: 272963448.2758621
Inventory turnover: 2.0606206979833352
Receivables turnover: 9.249629190151289
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7794556712421479
FCF margin (%): -188.77984637834547
Rule of 40 score: -188.77984637834547
Financial ratios for RFF.AX — annual report dated 2023-06-30
Total revenue: 50536423.8410596
Gross profit: 36109933.77483444
Operating income: 14221854.304635761
Net income: 62581456.95364238
Capital expenditures: 53085430.46357616
Depreciation & amortization: 8225827.814569537
Net tangible assets: 549926490.0662252
Owner earnings: 17721854.304635756
Return on net tangible assets (%): 3.2225860410000604
Capex to operating income (%): 373.2665890570431
Buffett classification: The Gruesome
Stock price: 0.9735099337748344
P/E ratio: 6.062486068805688
Shares outstanding: 389722999
Book value: 657721192.0529802
P/B ratio: 0.5768389638819161
Market cap (USD): 379399210.9470199
Debt to equity: 0.645025620268255
Current ratio: 0.6529983945603929
Quick ratio: 0.34800264425347066
Effective tax rate (%): -0.3472406579520234
Interest coverage ratio: 1.2426942885249697
COGS to revenue (%): 28.546717337177302
Free cash flow (dilution-adjusted): -41661589.40397351
Buyback yield (%): 0
Retained earnings: 309956291.3907285
Inventory turnover: 1.349021550656428
Receivables turnover: 7.231119113048422
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3272033739085722
FCF margin (%): -82.43873673175207
Revenue growth (%): 17.505836291169842
Rule of 40 score: -64.93290044058223
Financial ratios for RFF.AX — annual report dated 2024-06-30
Total revenue: 63373333.333333336
Gross profit: 45302000
Operating income: 18989333.333333332
Net income: 55498000
Capital expenditures: 23745333.333333332
Depreciation & amortization: 10508666.666666666
Net tangible assets: 584325333.3333334
Owner earnings: 42261333.33333333
Return on net tangible assets (%): 7.232500616095142
Capex to operating income (%): 125.04563965735149
Buffett classification: The Gruesome
Stock price: 1.1733333333333333
P/E ratio: 8.239485846216681
Shares outstanding: 389722999
Book value: 714211333.3333334
P/B ratio: 0.6402516512292813
Market cap (USD): 457274985.49333334
Debt to equity: 0.7353033695908867
Current ratio: 1.6910274058315604
Quick ratio: 1.420562418435025
Effective tax rate (%): 1.3719960765080923
Interest coverage ratio: 1.3849370350561578
COGS to revenue (%): 28.515674310961497
Free cash flow (dilution-adjusted): -24926000
Buyback yield (%): 0
Retained earnings: 364466666.6666667
Inventory turnover: 1.7917245026108797
Receivables turnover: 4.628493524199046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.543616486847232
FCF margin (%): -39.33200084157374
Revenue growth (%): 25.401301707945667
Rule of 40 score: -13.930699133628071
Financial ratios for RMC.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0827067669172932
Shares outstanding: 395529000
Market cap (USD): 428241924.8120301
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMC.AX — annual report dated 2022-06-30
Total revenue: 173669655.1724138
Net income: 70446206.89655173
Capital expenditures: 367586.2068965517
Depreciation & amortization: 1696551.7241379311
Net tangible assets: 241773793.10344827
Owner earnings: 71775172.4137931
Return on net tangible assets (%): 29.68691167577559
Buffett classification: The Gruesome
Stock price: 0.48275862068965514
P/E ratio: 2.7105083849745952
Shares outstanding: 395529000
Book value: 260736551.72413826
P/B ratio: 0.732329369319804
Market cap (USD): 190945034.4827586
Debt to equity: 43.11275220330729
Effective tax rate (%): 28.797574236721037
COGS to revenue (%): 0
SG&A to revenue (%): 20.54792888599442
Free cash flow (dilution-adjusted): -1093770344.8275862
Buyback yield (%): 2.862351071964021
Retained earnings: 199033793.10344827
Receivables turnover: 44.48348348348348
Capitalized R&D asset: 0
FCF margin (%): -629.799341595816
Rule of 40 score: -629.799341595816
Financial ratios for RMC.AX — annual report dated 2023-06-30
Total revenue: 131059602.64900662
Net income: 44012582.781456955
Capital expenditures: 116556.29139072848
Depreciation & amortization: 1604635.761589404
Net tangible assets: 256221192.05298012
Owner earnings: 45500662.25165562
Return on net tangible assets (%): 17.758352416941072
Buffett classification: The Gruesome
Stock price: 0.3973509933774834
P/E ratio: 3.5708843046088563
Shares outstanding: 395529000
Book value: 280462251.6556301
P/B ratio: 0.5603743110947376
Market cap (USD): 157163841.05960265
Debt to equity: 34.19246135755057
Effective tax rate (%): 30.32552288095613
COGS to revenue (%): 0
SG&A to revenue (%): 28.429509853461344
Free cash flow (dilution-adjusted): 1335888741.7218542
Buyback yield (%): 2.1877873261716165
Retained earnings: 213822516.5562914
Receivables turnover: 56.99884792626729
Capitalized R&D asset: 0
FCF margin (%): 1019.298635674583
Revenue growth (%): -24.53511667372475
Rule of 40 score: 994.7635190008583
Financial ratios for RMC.AX — annual report dated 2024-06-30
Total revenue: 91007333.33333333
Net income: 23194000
Capital expenditures: 45333.333333333336
Depreciation & amortization: 1520000
Net tangible assets: 258447333.33333334
Owner earnings: 24668666.666666668
Return on net tangible assets (%): 9.544949196612592
Buffett classification: The Gruesome
Stock price: 0.4066666666666667
P/E ratio: 6.9349167888246965
Shares outstanding: 395529000
Book value: 281780000
P/B ratio: 0.5708299382496984
Market cap (USD): 160848460
Debt to equity: 34.12342726003738
Effective tax rate (%): 30.57212987168486
COGS to revenue (%): 0
SG&A to revenue (%): 39.490590501864325
Free cash flow (dilution-adjusted): -71686000
Buyback yield (%): 0.6113414659570463
Retained earnings: 218240666.66666666
Receivables turnover: 26.973127840347757
Capitalized R&D asset: 0
FCF margin (%): -78.76947645244707
Revenue growth (%): -30.560346976587503
Rule of 40 score: -109.32982342903458
Financial ratios for RTAC — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -445972
Net income: 794834
Capital expenditures: 0
Operating cash flow: -411890
Net tangible assets: 233927682
Owner earnings: 794834
Return on net tangible assets (%): 0.33977765829355755
Buffett classification: The Gruesome
Stock price: 11.8
P/E ratio: 89.63192314370046
Shares outstanding: 24150000
Book value: 233927682
P/B ratio: 1.2181969981645868
Market cap (USD): 284970000
Debt to equity: 0
Current ratio: 1.9884092635389563
Quick ratio: 1.9884092635389563
Free cash flow (dilution-adjusted): -411890
Buyback yield (%): 0
Retained earnings: -9417575
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.18280825988099483
Rule of 40 score: 0
Financial ratios for RTAC — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -337479
Net income: 2176664
Capital expenditures: 0
Operating cash flow: -721705
Net tangible assets: 236104346
Owner earnings: 2176664
Return on net tangible assets (%): 0.9219076382439823
Buffett classification: The Gruesome
Stock price: 10.91
P/E ratio: 88.66790420185374
Shares outstanding: 24150000
Book value: 236104346
P/B ratio: 1.1159324445472087
Market cap (USD): 263476500
Debt to equity: 0.001058853867941931
Current ratio: 12.920564084255624
Quick ratio: 12.920564084255624
Free cash flow (dilution-adjusted): -721705
Buyback yield (%): 0
Retained earnings: -9753180
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1369317387011383
Rule of 40 score: 0
Financial ratios for RTAC — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1025873
Net income: 5055742
Capital expenditures: 0
Operating cash flow: -991948
Net tangible assets: 238188590
Owner earnings: 5055742
Return on net tangible assets (%): 2.1225794233048694
Buffett classification: The Gruesome
Stock price: 10.67
P/E ratio: 50.967889579808464
Shares outstanding: 24150000
Book value: 238188590
P/B ratio: 1.081833936713761
Market cap (USD): 257680500
Debt to equity: 0.001049588479448155
Current ratio: 10.676633416458852
Quick ratio: 10.676633416458852
Free cash flow (dilution-adjusted): -991948
Buyback yield (%): 0
Retained earnings: -9995603
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4127073686336358
Rule of 40 score: 0
Financial ratios for RTAC — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -242423
Net income: 2084244
Capital expenditures: 0
Operating cash flow: 141647
Net tangible assets: 238188590
Owner earnings: 2084244
Return on net tangible assets (%): 0.8750393963035761
Buffett classification: The Gruesome
Stock price: 10.67
P/E ratio: 50.967889579808464
Shares outstanding: 24150000
Book value: 238188590
P/B ratio: 1.081833936713761
Market cap (USD): 257680500
Debt to equity: 0.001049588479448155
Current ratio: 10.676633416458852
Quick ratio: 10.676633416458852
Free cash flow (dilution-adjusted): 141647
Buyback yield (%): 0
Retained earnings: -9995603
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09752645641933444
Rule of 40 score: 0
Financial ratios for RXRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.13
Shares outstanding: 524677865
Market cap (USD): 8987731827.449999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXRX — annual report dated 2022-12-31
Total revenue: 39681000
Gross profit: -8594000
Operating income: -245727000
Net income: -239476000
Capital expenditures: 37059000
Operating cash flow: -83524000
Depreciation & amortization: 11756000
Net tangible assets: 483699000
Owner earnings: -264779000
Return on net tangible assets (%): -54.74044808858402
Buffett classification: The Gruesome
Stock price: 7.71
Shares outstanding: 524677865
Book value: 485806000
P/B ratio: 8.326917203883854
Market cap (USD): 4045266339.15
Debt to equity: 0.10499046944665154
Current ratio: 5.683079838428165
Quick ratio: 5.683079838428165
Interest coverage ratio: -4467.763636363637
COGS to revenue (%): 121.6577203195484
R&D to revenue (%): 392.3691439227842
SG&A to revenue (%): 205.63745873339886
Free cash flow (dilution-adjusted): -148792000
Buyback yield (%): 0
Retained earnings: -639556000
Receivables turnover: 14.413730475844533
Capitalized R&D asset: 155696000
ROCI (R&D-adjusted, %): -18.755927453475685
FCF margin (%): -374.9703888510874
Rule of 40 score: -374.9703888510874
Financial ratios for RXRX — annual report dated 2023-12-31
Total revenue: 43876000
Gross profit: 1289000
Operating income: -350060000
Net income: -328066000
Capital expenditures: 11955000
Operating cash flow: -287780000
Depreciation & amortization: 24402000
Net tangible assets: 374937000
Owner earnings: -315619000
Return on net tangible assets (%): -84.17920877374065
Buffett classification: The Gruesome
Stock price: 9.86
Shares outstanding: 524677865
Book value: 463436000
P/B ratio: 11.16297341790452
Market cap (USD): 5173323748.9
Debt to equity: 0.10933980096496604
Current ratio: 4.702503998025136
Quick ratio: 4.702503998025136
Interest coverage ratio: -3608.865979381443
COGS to revenue (%): 97.06217522107758
R&D to revenue (%): 549.7903181693864
SG&A to revenue (%): 252.57999817667974
Free cash flow (dilution-adjusted): -353835000
Buyback yield (%): 0
Retained earnings: -967622000
Receivables turnover: 14.180995475113122
Capitalized R&D asset: 345542320
ROCI (R&D-adjusted, %): -26.61397553926425
Rosenberg metric: 0.0634762614325352
FCF margin (%): -806.443157990701
Revenue growth (%): 10.571810186235226
Rule of 40 score: -795.8713478044658
Financial ratios for RXRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.59
Shares outstanding: 524677865
Market cap (USD): 3457627130.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXRX — annual report dated 2024-12-31
Total revenue: 58488000
Gross profit: 13250000
Operating income: -479004000
Net income: -463661000
Capital expenditures: 13695000
Operating cash flow: -359174000
Depreciation & amortization: 36494000
Net tangible assets: 550054000
Owner earnings: -440862000
Return on net tangible assets (%): -80.14885811211263
Buffett classification: The Gruesome
Stock price: 6.76
Shares outstanding: 524677865
Book value: 1034782000
P/B ratio: 3.4276034637247266
Market cap (USD): 3546822367.4
Debt to equity: 0.10484527175772289
Current ratio: 3.8100036272083297
Quick ratio: 3.8100036272083297
Interest coverage ratio: -304.70992366412213
COGS to revenue (%): 77.34578033100807
R&D to revenue (%): 537.5820681165367
SG&A to revenue (%): 304.6505266037478
Free cash flow (dilution-adjusted): -457907000
Buyback yield (%): 0
Retained earnings: -1431283000
Receivables turnover: 1.189602570882317
Capitalized R&D asset: 527422100
ROCI (R&D-adjusted, %): -22.45940902195101
Rosenberg metric: 0.04958420734083391
FCF margin (%): -782.907604978799
Revenue growth (%): 33.30294466222992
Rule of 40 score: -749.604660316569
Financial ratios for RXRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.76
Shares outstanding: 524677865
Market cap (USD): 3546822367.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXRX — quarterly report dated 2025-03-31
Total revenue: 14818000
Gross profit: -7011000
Operating income: -191368000
Net income: -202487000
Capital expenditures: 1832000
Operating cash flow: -131957000
Depreciation & amortization: 19331000
Net tangible assets: 440045000
Owner earnings: -184988000
Return on net tangible assets (%): -42.0384278880569
Buffett classification: The Gruesome
Stock price: 5.29
Shares outstanding: 524677865
Book value: 933947000
P/B ratio: 2.971845196622507
Market cap (USD): 2775545905.85
Debt to equity: 0.09948101980090947
Current ratio: 4.114247681027743
Quick ratio: 4.114247681027743
Interest coverage ratio: -376.70866141732284
COGS to revenue (%): 147.31407747334325
R&D to revenue (%): 874.8414090970442
SG&A to revenue (%): 368.8082062356593
Free cash flow (dilution-adjusted): -169847000
Buyback yield (%): 0
Retained earnings: -1633694000
Receivables turnover: 0.32126441765675134
Capitalized R&D asset: 129634000
ROCI (R&D-adjusted, %): -8.11713114396953
FCF margin (%): -1146.220812525307
Rule of 40 score: -1146.220812525307
Financial ratios for RXRX — quarterly report dated 2025-06-30
Total revenue: 19103000
Gross profit: -1058000
Operating income: -176227000
Net income: -171897000
Capital expenditures: 3150000
Operating cash flow: -76418000
Depreciation & amortization: 23849000
Net tangible assets: 413557000
Owner earnings: -151198000
Return on net tangible assets (%): -36.56037740867644
Buffett classification: The Gruesome
Stock price: 5.06
Shares outstanding: 524677865
Book value: 919146000
P/B ratio: 2.888409454972333
Market cap (USD): 2654869996.8999996
Debt to equity: 0.09582264406307595
Current ratio: 3.5796763927670003
Quick ratio: 3.5796763927670003
Interest coverage ratio: -367.13958333333335
COGS to revenue (%): 105.53839711040152
R&D to revenue (%): 673.3811443228813
SG&A to revenue (%): 244.21818562529447
Free cash flow (dilution-adjusted): -107885000
Buyback yield (%): 0
Retained earnings: -1805589000
Receivables turnover: 0.8841525502175321
Capitalized R&D asset: 215490780
ROCI (R&D-adjusted, %): -9.87435713193672
Rosenberg metric: 0.045921594643380595
FCF margin (%): -564.7542270847512
Revenue growth (%): 28.917532730462952
Rule of 40 score: -535.8366943542882
Financial ratios for RXRX — quarterly report dated 2025-09-30
Total revenue: 4983000
Gross profit: -9704000
Operating income: -172202000
Net income: -162253000
Capital expenditures: 243000
Operating cash flow: -117360000
Depreciation & amortization: 21043000
Net tangible assets: 562562000
Owner earnings: -141453000
Return on net tangible assets (%): -25.144428525211442
Buffett classification: The Gruesome
Stock price: 4.88
Shares outstanding: 524677865
Book value: 1046948000
P/B ratio: 2.445611416421828
Market cap (USD): 2560427981.2
Debt to equity: 0.07868012546945981
Current ratio: 4.604069553780391
Quick ratio: 4.604069553780391
Interest coverage ratio: -206.7250900360144
COGS to revenue (%): 294.7421232189444
R&D to revenue (%): 2429.5003010234796
SG&A to revenue (%): 835.4003612281758
Free cash flow (dilution-adjusted): -142846000
Buyback yield (%): 0
Retained earnings: -1967879000
Receivables turnover: 0.22743039707895937
Capitalized R&D asset: 250027340
ROCI (R&D-adjusted, %): -11.882897360109002
Rosenberg metric: -0.06721291084921795
FCF margin (%): -2866.666666666667
Revenue growth (%): -73.91509187038685
Rule of 40 score: -2940.5817585370537
Financial ratios for RXRX — quarterly report dated 2025-12-31
Total revenue: 35351000
Gross profit: 21076000
Operating income: -108334000
Net income: -108121000
Capital expenditures: 1244000
Operating cash flow: -46073000
Depreciation & amortization: 19478000
Net tangible assets: 658804000
Owner earnings: -89887000
Return on net tangible assets (%): -13.643966946163047
Buffett classification: The Gruesome
Stock price: 4.09
Shares outstanding: 524677865
Book value: 1130865000
P/B ratio: 1.8976026916121727
Market cap (USD): 2145932467.85
Debt to equity: 0.06894280042268529
Current ratio: 5.503090577968546
Quick ratio: 5.503090577968546
COGS to revenue (%): 40.38075301971656
R&D to revenue (%): 271.3926055840004
SG&A to revenue (%): 95.2080563491839
Free cash flow (dilution-adjusted): -71080000
Buyback yield (%): 0
Retained earnings: -2076002000
Receivables turnover: 1.4341758286340216
Capitalized R&D asset: 219501420
ROCI (R&D-adjusted, %): -8.254392324475129
Rosenberg metric: 0.254249888486891
FCF margin (%): -201.0692766824135
Revenue growth (%): 609.432069034718
Rule of 40 score: 408.3627923523045